Ocular Toxoplasmosis
What's New
Last Posted: Jul 17, 2024
- Role of interleukin 1? and interleukin 10 variants on ocular toxoplasmosis in Brazilian individuals.
Warlen Miiller Rocha Araujo, et al. Frontiers in ophthalmology 2024 0 1183167 - Interleukin 17F Gene Polymorphism as a Potential Protective Factor in the Immunopathology of Ocular Toxoplasmosis.
Danilo Donizete da Silva, et al. Parasite immunology 2024 0 (5) e13038 - Automated Machine Learning versus Expert-Designed Models in Ocular Toxoplasmosis: Detection and Lesion Localization Using Fundus Images.
Daniel Milad et al. Ocul Immunol Inflamm 2024 1-7 - Genetic Variations in the Purinergic P2X7 Receptor Are Associated with the Immune Response to Ocular Toxoplasmosis in Colombia.
Carlos A Naranjo-Galvis, et al. Microorganisms 2023 0 (10) - Influence of killer immunoglobulin-like receptors genes on the recurrence rate of ocular toxoplasmosis in Brazil.
Perce-da-Silva Daiana de Souza, et al. Memorias do Instituto Oswaldo Cruz 2023 0 e220203 - CCR5 chemokine receptor gene polymorphisms in ocular toxoplasmosis.
de Faria Junior Geraldo M, et al. Acta tropica 2017 0 276-280 - Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular Toxoplasmosis.
Naranjo-Galvis C A, et al. Infection and immunity 2018 0 (4) - Toxoplasmic retinochoroiditis: The influence of age, number of retinochoroidal lesions and genetic polymorphism for IFN-? +874 T/A as risk factors for recurrence in a survival analysis.
Aleixo Ana Luisa Quintella do Couto, et al. PloS one 2019 0 (2) e0211627 - Serotyping, host genes and cytokines response in human ocular toxoplasmosis.
Mantilla-Muriel Luz Eliana, et al. Microbial pathogenesis 2020 0 104465 - A Trust-Based Methodology to Evaluate Deep Learning Models for Automatic Diagnosis of Ocular Toxoplasmosis from Fundus Images.
Parra Rodrigo et al. Diagnostics (Basel, Switzerland) 2021 11(11)
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: